PRQRのROE（自己資本利益率）は？

PROQR THERAPEUTICS BVのROEは-121.22%です。

PRQRの配当利回りは？

PROQR THERAPEUTICS BVの配当利回りは0.00%です。

PRQRの品質スコア（Quality Score）は？

当社のAIはPRQRの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

PRQRは今が買い時ですか？

当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

PRQRはどのセクターに属しますか？

PROQR THERAPEUTICS BVはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

PRQR (NASDAQ) 株価分析 | PROQR THERAPEUTICS BV

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

PRQR AI Analysis Summary

Our AI summary for PRQR: PROQR THERAPEUTICS BV (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -121.22%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

PRQR

PROQR THERAPEUTICS BV

US:NASDAQ STOCK Healthcare >> Biotechnology News 91

USD 1.72

-0.06 (-3.37%) Day Change

Watchlist Portfolio Compare Chart

0.12

D/E

-121.2%

ROE

-46.0%

ROA

0.00%

Div Yield

PROQR THERAPEUTICS BV
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.72 Price -0.06 (-3.37%) Day Change	NEWS SCORE: 91

PRQR, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.72
PBV / Sector	6.67 / 5.20
Earning Per Share	-0.31

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	1.76 M GREAT
Average 1W Daily Value	1.08 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-339.41 / 98.71
NPM Average (%) / Sector	-595.14 / -1,721.76
NPM Change Average (%) / Sector	-8.33 / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-46.02 / 27.02
ROA Average (%) / Sector	-30.91 / -368.17
ROA Change Average (%) / Sector	21.03 / 5,404.12 GREAT
ROE (%) / Sector	-121.22 / 3.47
ROE Average (%) / Sector	-78.45 / 6.51
ROE Change Average (%) / Sector	31.13 / 2,128.13 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 08:00:21
Symbol	PRQR
Name	PROQR THERAPEUTICS BV
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	141.12 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	251.20 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Zernikedreef 9, Leiden, Netherlands, 2333 CK

Phone: 31 88 166 7000

Website: https://www.proqr.com

Employees: 186

Sector: Healthcare >> Biotechnology

Description: ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. The company also develops AX-2402, which targets methyl CpG binding protein 2 mutations for Rett syndrome; AX-2911, which targets PNPLA3 for metabolic dysfunction-associated steatohepatitis; and AX-1412, which targets the B4GALT1 gene for cardiovascular diseases. It has a research and collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.